TONIX PHARMACEUTICALS HOLDING CORP. (TNXP)

13.59 +0.22% (+0.03)

Over 1M: +35.8%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

10 12
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -12.9M Q3 '21 — Free Cash Flow: -20.7M Q3 '21 — Net Income: -18.5M Q4 '21 — Operating Cash Flow: -22.4M Q4 '21 — Free Cash Flow: -48.1M Q4 '21 — Net Income: -29.6M Q1 '22 — Operating Cash Flow: -31M Q1 '22 — Free Cash Flow: -51.3M Q1 '22 — Net Income: -26.4M Q2 '22 — Operating Cash Flow: -21.2M Q2 '22 — Free Cash Flow: -35.6M Q2 '22 — Net Income: -23.1M Q3 '22 — Operating Cash Flow: -23.5M Q3 '22 — Free Cash Flow: -32.4M Q3 '22 — Net Income: -29M Q4 '22 — Operating Cash Flow: -22.3M Q4 '22 — Free Cash Flow: -27M Q4 '22 — Net Income: -31.7M Q1 '23 — Operating Cash Flow: -32.9M Q1 '23 — Free Cash Flow: -36.7M Q1 '23 — Net Income: -33M Q2 '23 — Operating Cash Flow: -23.4M Q2 '23 — Free Cash Flow: -25.2M Q2 '23 — Net Income: -28.4M Q3 '23 — Revenue: 4M Q3 '23 — Operating Cash Flow: -23.4M Q3 '23 — Free Cash Flow: -25.2M Q3 '23 — Net Income: -28M Q4 '23 — Revenue: 3.8M Q4 '23 — Operating Cash Flow: -22.3M Q4 '23 — Free Cash Flow: -22.8M Q4 '23 — Net Income: -27.3M Q1 '24 — Revenue: 2.5M Q1 '24 — Operating Cash Flow: -17.6M Q1 '24 — Free Cash Flow: -17.7M Q1 '24 — Net Income: -14.9M Q2 '24 — Revenue: 2.2M Q2 '24 — Operating Cash Flow: -9.9M Q2 '24 — Free Cash Flow: -9.9M Q2 '24 — Net Income: -78.8M Q3 '24 — Revenue: 2.8M Q3 '24 — Operating Cash Flow: -18.8M Q3 '24 — Free Cash Flow: -18.8M Q3 '24 — Net Income: -14.2M Q4 '24 — Revenue: 2.6M Q4 '24 — Operating Cash Flow: -14.6M Q4 '24 — Free Cash Flow: -14.6M Q4 '24 — Net Income: -22.1M Q1 '25 — Revenue: 2.4M Q1 '25 — Operating Cash Flow: -16.6M Q1 '25 — Free Cash Flow: -16.6M Q1 '25 — Net Income: -16.8M Q2 '25 — Revenue: 2M Q2 '25 — Operating Cash Flow: -14.8M Q2 '25 — Free Cash Flow: -15.4M Q2 '25 — Net Income: -28.3M Q3 '25 — Revenue: 3.3M Q3 '25 — Operating Cash Flow: -28.8M Q3 '25 — Free Cash Flow: -29.7M Q3 '25 — Net Income: -32M Q4 '25 — Revenue: 5.4M Q4 '25 — Operating Cash Flow: -39.6M Q4 '25 — Free Cash Flow: -41.5M Q4 '25 — Net Income: -46.9M Q1 '26 — Revenue: 6.9M Q1 '26 — Operating Cash Flow: -42.3M Q1 '26 — Free Cash Flow: -44M Q1 '26 — Net Income: -40.2M Q2 '26 — Revenue: 13.5M Q2 '26 — Operating Cash Flow: -42.2M Q2 '26 — Free Cash Flow: -42.8M Q2 '26 — Net Income: -40.6M -60M -40M -20M 0 20M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 27.3%
OE margin -570.6%
Oper. margin -568.4%
ROIC -443.4%
Accruals -2.6%
Gross margin 83.8%
EBITDA margin -561.1%
FCF margin -543.3%
OCF margin -525.7%
Profit margin -548.6%
ROA -62.8%
ROCE -74.1%
ROE -71.8%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
RPO / sales 0.13×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -1858.7×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 6.5×
Cash runway 1.2 yr
F-score 4.5 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -74.4%
Sales Q/Q +577.9%
Shares change +1057.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.